InsidersTradesSigma
Follow the 바이오텐 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 바이오텐 has published 9 insider filings. The latest transaction was filed on 6 November 2025 (Sale). Among the most active insiders: 파인밸류자산운용. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
9 of 9 declarations
Bio10 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions in the healthcare sector.